Press

Vantage Shines Money Expo Colombia 2025 Industry Recognition

Vantage schittert op Money Expo Colombia 2025 met erkenning uit de sector en dynamische betrokkenheid

PORT VILA, Vanuatu, 14 juli 2025 /PRNewswire/ — Vantage Markets sloot een zeer succesvolle show af op Money Expo Colombia 2025 en markeerde daarmee zijn aanwezigheid op de tweede editie van een van Latijns-Amerika’s belangrijkste financiële evenementen. De beurs, die op 25 en 26 juni werd gehouden in het Ágora Bogotá Convention Center, bracht de […]

Vantage schittert op Money Expo Colombia 2025 met erkenning uit de sector en dynamische betrokkenheid Read Post »

Press
image 5031113 6791876

BC.GAME Unveils “Symbiote” – A Dark Sci-Fi Slot with Evolving Reels and 5,000x Potential

New slot title brings cinematic battles, 97.31% RTP, and up to 5,000x win potential to BC.GAME players BELIZE CITY, Belize, July 13, 2025 /PRNewswire/ — BC.GAME is adding a dark twist to its slot lineup with the launch of Symbiote, a high-volatility crypto slot developed by Croco Gaming. Inspire by the cult comic Venom, the game

BC.GAME Unveils “Symbiote” – A Dark Sci-Fi Slot with Evolving Reels and 5,000x Potential Read Post »

Press
image 19

METABORA Partners with LINE NEXT to Distribute Web3 Games via Mini Dapp

METABORA becomes core partner in web3 game development for LINE NEXT’s Dapp Portal BORA Utility to Expand through in-game payments and gas abstraction Implementation SEONGNAM, South Korea, July 13, 2025 /PRNewswire/ — METABORA (Co-CEOs Lim Young-Jun and Choi Se-hoon), a global casual game developer and blockchain project operator, today announced a strategic partnership with LINE NEXT

METABORA Partners with LINE NEXT to Distribute Web3 Games via Mini Dapp Read Post »

Press
Logo 3

CARsgen Successfully Defends Its GPC3 CAR-T Patent at the EPO

SHANGHAI, July 13, 2025 /PRNewswire/ — CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces a favorable outcome in opposition proceedings before the European Patent Office (EPO) concerning its European patent EP3445407, which covers its GPC3-targeted CAR-T cell therapy. On July 3, 2025, a U.S.-based biotechnology —

CARsgen Successfully Defends Its GPC3 CAR-T Patent at the EPO Read Post »

Press
Monster Energy UFC

Monster Energy’s Derrick Lewis Knocks out Tallison Teixeira In 35 Seconds at UFC Fight Night in Nashville

40-Year-Old from New Orleans, Louisiana Shuts Down Heavyweight Fight with Round 1 K.O., Extends Career UFC Record for Knockout Victories at 16 Knockouts NASHVILLE, Tenn., July 13, 2025 /PRNewswire/ — Dominant victory for the “Knockout King”! Monster Energy congratulates MMA athlete Derrick Lewis on defeating Tallison Teixeira in the main event fight at UFC Fight Night

Monster Energy’s Derrick Lewis Knocks out Tallison Teixeira In 35 Seconds at UFC Fight Night in Nashville Read Post »

Press

XIFR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that XPLR Infrastructure, LP Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NEW YORK, July 13, 2025 /PRNewswire/ — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against XPLR Infrastructure, LP (“XPLR” or “the Company”) (NYSE: XIFR) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for

XIFR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that XPLR Infrastructure, LP Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Read Post »

Press

IOVA Deadline: IOVA Investors with Losses in Excess of $100K Have Opportunity to Lead Iovance Biotherapeutics, Inc. Securities Fraud Lawsuit

NEW YORK, July 13, 2025 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, reminds purchasers of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) securities between May 9, 2024 and May 8, 2025, both dates inclusive (the “Class Period”), of the important July 14, 2025 lead plaintiff deadline. So What: If you purchased Iovance securities during

IOVA Deadline: IOVA Investors with Losses in Excess of $100K Have Opportunity to Lead Iovance Biotherapeutics, Inc. Securities Fraud Lawsuit Read Post »

Press
Scroll to Top